BAX:NYSE
Baxter International Inc
$24.36
arrow_upward
+0.58%(+0.14) 1D
$24.29
arrow_downward
-0.29% (-0.070)bedtimeAfter hours
Closed: Oct 6, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BAX...
Open
$24.32
High
$24.42
Low
$23.92
Mkt. cap
12.21B
Avg. vol.
6.34M
Volume
6.52M
Dividend
0.16%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$2.07
Beta
0.66
Shares outstanding
517.00M
No. of employees
38K
Open
$24.32
High
$24.42
Low
$23.92
Mkt. cap
12.21B
Avg. vol.
6.34M
Volume
6.52M
Dividend
0.16%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$2.07
Beta
0.66
Shares outstanding
517.00M
No. of employees
38K
News stories
From web sources and news partners
AD HOC NEWS
·
5 minutes ago
Citigroup cuts target for Baxter International stock from USD 28.00 to USD 27.00
Zacks
·
12 hours ago
Are Investors Undervaluing Baxter International (BAX) Right Now?
Yahoo Finance
·
13 hours ago
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37.5K
Founded1931
HeadquartersDeerfield, Illinois, United States
SectorMedical device
Websitebaxter.com